" MiMedx still has an unresolved untitled letter from the Food and Drug Administration to deal with, and until we have better clarity on its ability to continue to manufacture its products with the blessing of the FDA, I'd suggest keeping your distance."
It's INJECTABLE business only.
"Conversely, the confirmation of the receipt of an untitled letter solidifies the seriousness of these allegations and poses the potential to put a serious dent in MiMedx's revenue growth."
How? Injectables is projected at ~15% of revenue.
Epifix Micronized is physician choice and Amniofix doesn't generate much revenue. Amniofix isn't covered by majority of payers and will require additional studies regardless of how the FDA rules. Injectables won't be a driver of revenue for at least 5-10 years.
Unless Sean is projecting huge legal fees/settlement
Like 95% of journalists, he doesn't actually know anything about the company. Just reads a PR about the FDA letter and writes. I just commented on the website but might take 15 minutes to show up, if they post it at all